Raymond Jacobsen, Jon Dubrow and Lisa Peterson advised Impax Laboratories in its purchase of generic epinephrine drug and injectors maker Tower Holdings and three of its subsidiaries for $700 million in cash.
We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.
